Corporate Information
CurXceL is a seed-stage biotechnology company planning to engage in the discovery and development of novel therapeutic drugs intended to treat neurodegenerative diseases such as Alzheimer's Disease.
- CurXceL Corp. ("CurXceL") was conceived in October of 2000 to cure Alzheimer's Disease ("AD").
- CurXceL was incorporated in March of 2001.
- CurXceL's Stocks are not publicly traded at this time.